APA (7th ed.) Citation

H, E., D, B., NJ, S., ZB, Z., N, D., L, M., . . . SK, P. (2024). Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy. Nutrients, 16(11), . https://doi.org/10.3390/nu16111630

Chicago Style (17th ed.) Citation

H, Ebrahimi, et al. "Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy." Nutrients 16, no. 11 (2024). https://doi.org/10.3390/nu16111630.

MLA (9th ed.) Citation

H, Ebrahimi, et al. "Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy." Nutrients, vol. 16, no. 11, 2024, https://doi.org/10.3390/nu16111630.